Logout
Lundbeck sites
Contact Us
About Azilect
Key publications
For your patients
Prescribing information
Azilect
®
– a well tolerated therapy
Azilect
®
(rasagiline) – a well tolerated therapy for early and moderate-to-advanced Parkinson's disease patients.
Parkinson’s disease animations
View the animations to learn more about Parkinson's disease. They can be helpful in communicating with your patients.
Azilect
®
– treating the symptoms of Parkinson's disease
Want to know more about Azilect
®
?
Azilect
®
(rasagiline) has demonstrated efficacy in 4 large clinical trials, both as monotherapy (TEMPO, ADAGIO) and as an adjunct to levodopa in Parkinson's disease patients (PRESTO, LARGO).
ADAGIO trial results show Azilect
®
slows clinical progression of Parkinson’s disease
The ADAGIO study showed that Parkinson's disease patients who took Azilect
®
(rasagiline) 1mg tablets once-daily upon entry into the trial, demonstrated a significant improvement...